MichaelJOvermanMD

PubMed

• Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling.
  Wang, X., Dasari, A., Shen, J., Drusbosky, L., Johnson, B., Morris, V., Raghav, K., Lee, M., Huey, R., Parseghian, C., Willis, J., Wolff, R., Overman, M., Kopetz, S.> ;Cancers. 2024 Feb 9
• Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Mohammad A Zeineddine, Aditya More, Mohammad Fanaeian, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Patt...> ;JAMA Network Open. 2024 Feb 5
• 1 citations
  Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G Smagl...> ;NPJ Precision Oncology. 2024 Feb 3
• Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
  Amaria, R., Knisely, A., Vining, D., Kopetz, S., Overman, M., Javle, M., Antonoff, M., Tzeng, C., Wolff, R., Pant, S., Lito, K., Rangel, K., Fellman, B., Yuan, Y., Lu,...> ;Journal for Immunotherapy of Cancer. 2024 Feb 2
• Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-...
  Cohen, R., Raeisi, M., Chibaudel, B., Yoshino, T., Shi, Q., Zalcberg, J., Adams, R., Cremolini, C., Grothey, A., Mayer, R., Van Cutsem, E., Tabernero, J., Bando, H., M...> ;European Journal of Cancer. 2024 Mar 1
• Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
  Stemmer, A., Margalit, O., Serpas, V., Strauss, G., Thomas, J., Shah, P., Tau, N., Levanon, K., Shacham-Shmueli, E., Boursi, B., Kopetz, S., Overman, M.> ;European Journal of Cancer. 2024 Feb 1
• Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
  Simmons, K., Thomas, J., Ludford, K., Willis, J., Higbie, V., Raghav, K., Johnson, B., Dasari, A., Kee, B., Parseghian, C., Lee, M., Le, P., Morelli, M., Shen, J., Ben...> ;Cancer Research Communications. 2023 Dec 11
• Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Ben...
  Neal Bhutiani, Travis E Grotz, Seth J Concors, Michael G White, Beth A Helmink, Kanwal P Raghav, Melissa W Taggart, Karen A Beaty, Richard E Royal, Michael J Overman, ...> ;Annals of Surgical Oncology. 2024 Jan 1
• 1 citations
  Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer.
  Daniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, Harmeet Kaur, Nancy You, Kanwal P S Raghav, Phillip S Ge, Craig Messick, Benny Johnson, Van K Morris, Jane V Thomas...> ;European Journal of Cancer. 2023 Nov 1
• Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma.
  Julia Dansby, Mohammad Zeineddine, Alisha Bent, Farshid Dayyani, Robert Wolff, Michael Overman, John Paul Shen, Aditya More, Abdelrahman Yousef> ;The Oncologist. 2023 Dec 11
• 9 citations
  The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, Aditya More, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Pattalachinti, Zahra Alav...> ;Medrxiv. 2023 Sep 11
• Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.
  Stefania Napolitano, Aparna R Parikh, Jason Henry, Christine M Parseghian, Jason Willis, Kanwal P Raghav, Van K Morris, Benny Johnson, Bryan K Kee, Arvind N Dasari, Mi...> ;JCO Precision Oncology. 2023 Sep 1
• Impact ofMutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G Smagl...> ;Research Square. 2023 Aug 10
• Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma.
  Yujie Zhang, Hua Wang, Michael Overman, Matthew Hg Katz, Huamin Wang> ;Human Pathology. 2023 Sep 1
• 3 citations
  Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer.
  Lauren M Janczewski, Amanda E Browner, Joseph H Cotler, Heidi Nelson, Sanjay Kakar, Norman J Carr, Nader N Hanna, Andreana N Holowatyj, Richard M Goldberg, M Kay Washi...> ;CA. 2023 Jun 26
• 6 citations
  Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial.
  John Paul Shen, Abdelrahman M Yousef, Fadl A Zeineddine, Mohammad A Zeineddine, Rebecca S Tidwell, Karen A Beaty, Lisa C Scofield, Safia Rafeeq, Nicholas Hornstein, El...> ;JAMA Network Open. 2023 Jun 1
• 4 citations
  Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Al B Benson, Alan P Venook, Mahmoud M Al-Hawary, Nilofer Azad, Yi-Jen Chen, Kristen K Ciombor, Stacey Cohen, Harry S Cooper, Dustin Deming, Ignacio Garrido-Laguna, Jea...> ;Journal of the National Comprehensive Cancer Network. 2023 Jun 1
• Publisher Correction: A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy.
  Gabriel Lopez, Cathy Eng, Michael Overman, David Ramirez, Wenli Liu, Curtiss Beinhorn, Pamela Sumler, Sarah Prinsloo, Yisheng Li, Minxing Chen, Eduardo Bruera, Lorenzo...> ;Scientific Reports. 2023 May 23
• 2 citations
  Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
  Ryan W Huey, Aakash Tushar Shah, Honey V Reddi, Priyadarsini Dasari, James T Topham, Hyunsoo Hwang, Nishat Dhillon, Anneleis Willett, Brandon G Smaglo, Jeannelyn S Est...> ;Journal of the National Cancer Institute. 2023 Aug 8
• 1 citations
  Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
  Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, Ramez Kouzy, Timothy A Lin, Brian De, Esther J Beck, Cullen M Taniguchi, Bruce D Minsky, Clifton D Fuller, J Jack L...> ;JAMA Network Open. 2023 May 1
• 7 citations
  BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
  Raphael Colle, Sara Lonardi, Marine Cachanado, Michael J Overman, Elena Elez, Francesca Corti, Priya Jayachandran, Magali Svrcek, Antoine Dardenne, Baptiste Cervantes,...> ;The Oncologist. 2023 Sep 7
• 13 citations
  First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
  Johanna Bendell, Patricia LoRusso, Michael Overman, Anne M Noonan, Dong-Wan Kim, John H Strickler, Sang-We Kim, Stephen Clarke, Thomas J George, Peter S Grimison, Mina...> ;Cancer Immunology, Immunotherapy. 2023 Jul 1
• 8 citations
  Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
  Timothy E Newhook, Timothy J Vreeland, James F Griffin, Rebecca S S Tidwell, Laura R Prakash, Eugene J Koay, Ethan B Ludmir, Brandon G Smaglo, Shubham Pant, Michael Ov...> ;Annals of Surgery. 2023 Mar 1
• Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neopl...
  Derek J Erstad, Kristen A Robinson, Karen Beaty, Safia Rafeeq, Yi-Ju Chiang, Kanwal Raghav, John P Shen, Michael J Overman, Wai Chin Foo, Melissa W Taggart, Paul F Man...> ;Langenbeck's Archives of Surgery. 2023 Feb 28
• Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot Study.
  Anaeze C Offodile 2nd, Domenica Delgado, Yu-Li Lin, Danielle Geyen, Christopher J Miller, Sanchita Jain, Janice P Finder, Sanjay Shete, Frank V Fossella, Michael J Ove...> ;JCO Oncology Practice. 2023 Jun 1
• Join now to see all

Journal Articles

• Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients with Cancer  
  Michael J Overman, Adi Diab, Patrick Hwu, JAMA Network Open
• Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge  
  B Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology

Lectures

• How to Approach Biomarker Testing for Colorectal Cancer in 2019 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
• A priori filtering of post-operative (post-op) circulating tumor DNA (ctDNA) to predict recurrence in post-metastasectomy colorectal cancer patients (CRC pts) without ... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (pa... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• Optimal Approach to Colorectal Cancer With Deficient Mismatch Repair (dMMR) 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Join now to see all

Other

• Diagnosis and staging of small bowel neoplasms 
  Overman MJ, Cusack JC
  http://www.uptodate.com/contents/diagnosis-and-staging-of-small-bowel-neoplasms
  UpToDate, Wolters Kluwer Health - 2013-01-16
• Treatment of small bowel neoplasms 
  Overman MJ, Cusack JC
  http://www.uptodate.com/contents/treatment-of-small-bowel-neoplasms
  UpToDate, Wolters Kluwer Health - 2012-11-01
• Epidemiology, clinical features, and types of small bowel neoplasms 
  Overman MJ, Cusack JC
  http://www.uptodate.com/contents/epidemiology-clinical-features-and-types-of-small-bowel-neoplasms
  UpToDate, Wolters Kluwer Health - 2012-07-27